Cardiovascular Disease

• Continue to work closely with Public Health partners on the CVD prevention agenda (smoking, obesity and healthy living) and implementation of effective and equitable NHS Health Checks.
• Continue to work with partners, pharmaceutical companies and the Academic Health Science Network (AHSN), to detect and medically optimise people with AF to prevent stroke.
• Continue to work with partners to detect and medically optimise people with hypertension to prevent CVD events.
• Continue to work with partners to detect and manage Inadequately Controlled Lipids, and to undertake cascade testing of family members to identify and medically optimise those with Familial Hypercholesterolemia.
• Improved systems to identify and manage people with heart failure (access to echocardiograph / rehabilitation services).

Atrial Fibrillation

• 30% reduction in number of patients who have not been anticoagulated, i.e. given blood thinners (where indicated).
• 80% reduction in number of patients who have not been risk assessed.
• 50% reduction in number of patients who are inadequately anti-coagulated when required.

Hypertension

• Increase in the number of patients detected with hypertension and to increase the number treated to bring blood pressure within recommended parameters.

Inadequately Controlled Lipids

• Improve the proportion of people who are likely to benefit from lipid modification who have been offered it.